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Genetic Toxicology: Current Status of
Methods of Carcinogen Identification
by Raymond W. Tennant' and Errol Zeiger'
Acriticalaspectoftheeffortstorelatetheresultsofshort-termgenetictoxicitytestswiththosefromlong-term rodent
testsforcarcinogens isthequality andconsistencyofthestudiesconductedbytheNationalToxicologyProgram. Analysis
ofthe results inrelationship tochemical structure hasshownthat mutagenic potential isa primary riskfactorforcar-
cinogen identification. Chemicals positive intheSalmonella assaygenerally possess "structural alerts" forelectrophilic
interactions, arepredominantly representedamongchemicals producing tmns-speciescarcinogenic effects in rodents,
andamongthose identified ascarcinogenic tohumans. Currenteffortsareaimed at defining toxicological, structural,
and mechanistic properties ofnonmutagens that arecarcinogenic in rodents.
Introduction
Genetic toxicology came intoexistence as a separatediscipline
in the mid-1960s. The origin ofthe field was tied to a growing
understanding of the mutagenic basis of some cancers and a
strong association between radiation, induced mutation, and
cancer. Developmentofthe field wasalsomotivatedby concerns
for the effects of chemicals and environmental factors on the
human genepool and thetransmission ofinducedmutations to
subsequent generations. Over a period of approximately 3
decades, the discipline has evolved significantly and has con-
tributed to a clearer understanding of relationships among
chemical structure, induced mutagenesis, and cancer. The con-
tributions ofgenetic toxicology tounderstandingtheroleofin-
duced mutations in heritable diseases is covered in another ar-
ticle in this issueby Shelby etal. (1). Inthis paper wesummarize
information derived principally from chemicals studied under
the aegis of the National Toxicology Program (NTP) and
describe relationships between chemical structures and
biological effects related to cancer. Wealso discuss in vitroand
short-term in vivo methods used for identifying potential
mutagens andcarcinogensandtheirvalueandlimitations. Inad-
dition, current efforts to improve methods ofcarcinogen iden-
tification and to understand the properties of carcinogenic
chemicals that are not mutagenic are summarized.
Assay Selection and Validation
The concept of "validation" of an assay implies that the
measured endpoint istruly acharacteristic ofthe systemandthat
the results of the assay are reproducible within and between
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laboratories. Variousapproachesandsolutionstotheproblems
ofvalidationhavebeenproposedoverthepasttwodecades and
haveoften involvedtheuseofchemicalsofknowncarcinogenic
potential. Suchchemicals were usedtodemonstrate thatapro-
posed assay system could detect or identify a majority ofsuch
carcinogens(defined as "sensitivity"). Anadequate validation
studyalsoinvolvestheaccurateidentificationofchemicalsthat
areknowntobenoncarcinogens. Suchvalidationof"specifici-
ty" is equally important for establishing the reliability of the
assay. Thedatabasegeneratedby the National Toxicology Pro-
gram contains equivalent numbers ofrodent carcinogens and
noncarcinogens.
Approximately 5-10 years ago there were clear indications
fromtheNTPstudiesthatthe strong relationshipthathadbeen
proposedbetween mutagenicity androdentcarcinogenicity, as
definedbydataderivedfromtheAmesSalmonellamutagenesis
test (2,3), had some deficiencies. Many chemicals were car-
cinogenic torodentsbutwere notidentified as mutagensby the
Salmonellatest(4-6). Theseobservationsledtoextensiveefforts
to search for other in vitro or short-term in vivo methods that
wouldcomplementtheSalmonellatestandleadtomethodsthat
wereuniformlypredictiveforcarcinogenicpotential. However,
anevaluationofpublishedreportsfromthesesystems, conducted
bytheU.S. Environmental ProtectionAgency (EPA) GeneTox
Program, revealed that there were major impediments to
reaching any conclusions about the capacity ofthese assays to
predictcarcinogens. First, inadequatenumbersofchemicals had
beentested incommonacrossthevariousassay systems toper-
mitany formofstatisticalcomparisons. Thatis, although some
assayshadbeenusedtotestalargenumberofchemicals, fewof
thechemicals were in commonwiththose tested inotherassay
systems. Second, thedatabasecontainedinadequatenumbersof
noncarcinogenic chemicals. For example, the EPA Gene-Tox
compilation ofchemicals tested in Salmonella contained only
4.4% noncarcinogens (7). Third, thedata wereoftenofincon-
sistent quality, both within and among assay systems. LittleTENNANTANDZEIGER
efforthadbeenmade tostandardize assays, andthere was agreat
deal ofuncertainty aboutwhich variables intheprotocol andtest
methodology produced the major sources ofvariation.
Test systems were initially selected for use intheNTPgenetic
toxicology testing programbased ontheirwidespread useandthe
extent to which the genetics oftheorganism was understood. It
was determined atthe outsetoftheprogram's developmentthat
only a limited numberoftests were sufficiently well developed
and used to provide information on the ability of achemical to
induce gene mutations and chromosome damage. The tests in-
itially selected were the Salmonella typhimurium/mammalian
microsome (Ames) test: measurement of thymidine kinase
resistance incultured mouselymphoma L5178Y cells; induction
ofchromosome aberrations and sister chromatid exchanges in
cultured Chinese hamster ovary cells; and induction of sex-
linked recessive lethal mutations and reciprocal translocations
in the fruit fly, Drosophila melanogaster (8). Later in the de-
velopmentofthe program, a numberofin vivocytogenetic tests
wasadded. These werethe measurementofchromosome aber-
rationsand sisterchromatidexchanges in mousebone marrow;
the measurementofmicronuclei in mouseand ratbone marrow,
and the measurement of micronuclei in peripheral blood
erythrocytes ofmice.
To be ofvalue in decision making, and to meet the rigorous
demands ofscientific validity, mutagenicity test results mustbe
reproducibleboth qualitatively andquantitatively. Thevalidation
procedures used entailed the testing of selected chemicals to
determine if the test truly measured what it was designed to
measure; assessing the intra- and interlaboratory reproducibility
of the tests; and development of standardized protocols (8,9).
Validation studies wereperformed with anumberofin vitroand
in vivo tests (4,10-19). Oneaspectoftest systemdevelopmentand
validation wasthedevelopment otstatistical proceduresand ap-
proaches fordeterminingtheacceptability ofthetestdataandfor
evaluating the test data (20-27).
Correlations with Carcinogenicity
Based onthe factors discussed above, theCellularandGenetic
Toxicology Branch of the National Insitute of Environmental
Health Sciences (NIEHS) conducted a large-scale objective
study directed atevaluating theutility ofgenetictoxicity tests for
identifying carcinogensanddetermining how thevarious short-
term tests and other information about achemical can be com-
bined toyield auseful predictionofachemical's carcinogenici-
ty. The overall structure of the study was to choose a random
group of chemicals that had recently undergone 2-year car-
cinogenicity bioassays in rodents. Thevalueofsuch anapproach
was that the chemicals were not preselected on the basis of
knowledge ofwhether they were carcinogenic, or on whether
they contained particular chemical structures. Second, based on
the general characteristics ofthe NTP database, this grouping
was expected to include a sizable proportion ofchemicals that
failed to showcarcinogenic potentialwhenmiceandrats were ex-
posed for 104weeks atmaximum-tolerated doses. This groupof
noncarcinogenic substances isextremely important to the con-
clusions that havebeen derived from the studies. Thedefinition
of noncarcinogenicity is obviously operational because if the
chemicals hadbeen administered by some other route, at some
otherdose, orto someotherrodentstrains orspecies, theremight
havebeen adifferenteffect. However, undertheconditions of
the bioassays under which many chemicals were identified as
carcinogens, the chemicals that were classified as noncar-
cinogens failed to induce neoplasia. Chemicals showing
equivocal evidenceofcarcinogenicity were considered noncar-
cinogens forthe purposes ofthis study.
To further ensure objectivity in the evaluation process, all
chemicals were tested in the genetic toxicity tests under code,
usingstandardizedprotocolsto removeallinvestigatorbias. All
testing wascompletedbeforetheresults wereinterpretedandthe
codewasbroken.Initially, 73chemicalsthathadundergone ro-
dentcarcinogenicity bioassays wereselected fortesting in four
in vitro assay systems. These assays included the Salmonella
(Ames) mutagenesis assay (SAL); inductionofmutations atthe
tklocus in L5178Y mouselymphomacells (MLA); and induc-
tionofchromosome aberrations (ABS) and sisterchromatid ex-
changes (SCE) inChinesehamster ovary (CHO) cells. A few of
the same73 chemicals weretestedinother assays. These assays
included mutagenesis in Drosophila; chromosome damage
(chromosome aberrations, SCE, and micronuclei) in rodent
bone marrow cells; induction ofunscheduled DNA synthesis
(UDS) inrodenthepatocytes; in vitromammaliancell transfor-
mation; andinhibitionofintercellularcommunication in vitro.
The results ofthe initial studies using SAL, MLA, ABS, and
SCE wereverified andextended by an independentstudy ofan
additional 41 chemicals, bringingtogether atotal of 114chemi-
cals forwhichboth long-termeffects in rodents as well as short-
term effects in vitro have been systematically evaluated (28).
Somegeneralized characteristics oftheassociations between
eachofthe fourprincipalin vitro assay systemsand rodent car-
cinogenesis arepresented inTable 1. The followingconclusions
were reached based on the initial 73 chemicals and verified by
theadditional 41 chemicals. Amongthe four assay systems, the
Salmonella assay demonstratedboththehighestspecificity and
the lowest sensitivity. Thepositivepredictivity ofSAL was the
highest (89% ofthe Salmonella-positive chemicals were car-
cinogens). Conversely the SCE and mouse lymphoma assays
had the highest sensitivities (69% and72%, respectively), but
the lowest positive predictivities (64% and 63%). Thus, the
Salmonella assay identifies ahighproportionofchemicals with
mutagenic potential that arealsocarcinogens, but a significant
Table 1. Operational characteristics ofin vitro genetic tests.
Test
SAL ABS SCE MLA
+ - + - + - + -
Carcinogenesis
+ 32 35 35 32 46 21 48 19
- 4 43 13 34 26 21 28 19
Significance of <0.0001 0.007 0.105 0.127
association, p
Sensitivity, % 48 52 69 72
Specificity, % 91 72 45 40
Positive predic- 89 73 64 63
tivity, %
Negative predic- 55 52 50 50
tivity, %
Concordance, % 66 61 59 59
Abbreviations: SAL, Salmonella (Ames) mutagenesis assay; ABS, induction
ofchromosome aberrations; SCE, sisterchromatid exchange; MLA induc-
tion ofmutations at the tk locus in L1578Y mouse lymphoma cells.
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number ofcarcinogens lackdemonstrable mutagenic potential
in this assay.
Inorderforatestbatterytobemoreeffectivethanindividual
tests for identifying carcinogens, the tests should complement
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FIGURE 1. Frequency distribution ofmutagensand nonmutagensas afunctionofchemical groupand level ofcarcinogenicity. *, Salmonellamutagen; O, Salmonella
nonmutagen. Level ofeffect: A, carcinogenic in ratsand miceatoneor moresites; B, carcinogenic inasingle species; C, carcinogenic atsinglesite in both sexes
ofasingle species; D, carcinogenic at asingle site in asingle sex ofasingle species; E, equivocal evidenceofcarcinogenicity; F, noncarcinogenic; M, mouse;
R, rat. Chemical group: AA, aromatic amino/nitro-type chemicals; Alk, naturalelectrophiles, including reactive halogens; Misc, minorgroupsofstructurally
alertingchemicals; inerthalogen, nonalertingchemicalscontaininganonreactivehalogen; minorstructuralconcerns, nonalertingchemicalsbutwithminorconcerns;
no structural alerts, chemicals devoid ofactual orpotentially electrophilic centers. Adapted from Ashby and Tennant (30).
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eachother. Thismeansthatclassesorgroupsofcarcinogensthat
are not identifiedby onetest shouldbepreferentially identified
byanother. There wasalackofcomplementarity amongthefour
assays: theseassays, forthe mostpart, identified the samecar-
cinogens. Any combination of the assays led to an increased
numberofcarcinogens correctly identified, butatthecostofan
equal numberofnoncarcinogens givingpositiveresults, the so-
called false positives. It was therefore concluded that no com-
binationoftests improvedthepredictivityoftheSalmonellatest
alone. The high degree ofagreementamong the tests indicates
that all oftheassay systems tend todetectsimilarchemicalpro-
perties, i.e., mutagenicity, butthattheassaysotherthanSAL, to
varying degrees, appearto respondpositively tootherchemical
properties that are not directly related to the capacity of the
chemicals to induce cancer.
These results have beenfortifiedby anexamination ofchemi-
cal substructure in relationship tocarcinogenicity (29-32). The
results presented in Figure 1 are derived from an analysis and
evaluation of 301 chemicals that have been tested for car-
cinogenicity in two rodent species and for mutagenicity in
Salmonella (30). The evaluation demonstrated some important
aspects ofthesechemical structure-activity relationships. First,
it is possible to group the chemicals that are mutagenic in
Salmonella into three broad structural categories. The three
structural categories that include themajority ofmutagens are
shown in the legend ofFigure 1 and include aromatic amines,
chemicals withalkylating functions, and aheterogeneous group
ofchemicals thatpossesshalogenatomsgenerally substituted in-
to a reactive position in the molecule. The fact that it has been
possible tocategorize virtually all ofthe 301 chemicals among
six broad structuralgroupings indicatesalsothattheselectionof
chemicals for testing in rodent bioassays over the past two
decades has notbeen a completely random process. Thus, this
selection ofchemicals is not necessarily representative ofthe
universe ofchemicalsthatarepresentintheenvironment, used
in commerceand medicine, etc. Thesechemicals representthose
that were selected fortesting to fulfill the needsofthedifferent
governmentagencies orthoseforwhichthere was someevidence
or suspicion that they might possess carcinogenicpotential.
Figure 1 alsostratifiesthechemicalsintosixlevelsofbiological
effect, which reflects theiractivity inthe2-yearrodentcarcino-
genicity studies. One measureoftherelativebiologicalpotency
ofthechemicalistheextenttowhichitisabletocrossspeciesor
to inducetumorsatmultipleversussinglesites.Theseresultsshow
thatahigherproportionofmutageniccarcinogens,asdefinedby
mutagenesisinSalmonella, inducedtrans-speciescarcinogenic
effectsthandidnonmutagens. Nonmutagens, ontheotherhand,
includedanincreasedproportionofchemicalsthatinducedsingle-
site and single sex-species carcinogenic effects (seebelow).
Studiesby others suggestedthatit maybepossible toidentify
someproportionofthenonmutageniccarcinogensbydetermin-
ing whetherthey have thecapacity to inducegenetictoxicity in
thewholeanimal. Theassays mostoftenused toestimatethisare
the inductionofmicronuclei, chromosomeaberrations, orsister
chromatidexchanges in rodentbone marrowcells. Ourevalua-
tionsoftheseassociationsare notyetcompleted, buttheresults
suggest that the carcinogenic mutagens often induce chromo-
somal aberrations ormicronuclei. Therefore, thesesystemsmay
supplement the data obtained in vitro or by observation of
chemical structure. However, there are also somedichotomies
in the data that indicate that the induction of chromosomal
damage in vivo alone will not be sufficient to adequately
discriminatebetweenallcarcinogensandnoncarcinogens. Later
inthisarticlewediscussthepotential applicationofmutagenesis
systems in transgenic mice toward this problem.
An interesting association has been identified by Shelby and
Zeiger(33)amongthechemicalsidentifiedasgroup1 humancar-
cinogens by the International Agency for Research on Cancer
(IARC). Withveryfewexceptions,theorganicsubstancesrepre-
sentedamongtheseagentsarealsomutagenicinSalmonella, in-
ducemicronucleiinrodentbonemarrowcells,andpossessstruc-
turalalertsasdefinedbyAshbyandTennant(30). Takentogether,
these results show that mutagenic chemicals have a high pro-
babilityofinducingcarcinogeniceffects inmultiplespeciesand
that these properties are also demonstrated by the majority of
chemicalsthathavebeenshowntocausehumancancers. Thus,
mutagenicity, as reflected both in chemical structure and
biologicalactivity, canbeusedasaprimary riskfactorforiden-
tifying chemicals with trans-species carcinogenic potential.
Althoughasignificantnumberofchemicalsthathavethecapaci-
tytoinducecancersfollowinglong-termexposures inrodentsfail
to show mutagenicity inSalmonellaand/orfor structural alerts,
thisdoes notdiminishthepositivevalueofmutagenicity assays.
Represented inthe result shown in Figure 1 are62 mutagens
thathavefailedtodemonstratecarcinogenicpotential inboth rats
and mice (levels E and F). Many ofthese chemicals are struc-
turally similar to mutagenic carcinogens. One plausible
hypothesis isthatthisfractionofmutagens, undertheconditions
tested, did notgaineffectiveaccesstothecellulargenome, even
upon chronic exposure ofrodents. This may be because such
chemicals are effectively metabolized or detoxified or are not
distributedtoappropriatetargettissuesinwhichtheycaninteract
to induceneoplasticchange. Theremay bemodifying chemical
substructuresassociated with such chemicals thatin some way
reducethecapacity forelectrophilic interactions, or there may
be other factors that are not yet understood.
AnotherinterestingaspecttothedatashowninFigure 1 isthat
the great majority of mutagenic chemicals that were not car-
cinogenswhentestedinbothratsandmiceoccurredinbioassays
that were conducted and evaluated during the 1970s. Of the
chemicalsplacedontestbytheNational CancerInstituteorthe
NTPupthrough 1980, approximately 31% ofthenoncarcinogens
and equivocal carcinogens were mutagenic in Salmonella; this
value was 10% for those chemicals placed on test after 1981.
These results may indicate that there have been changes in the
selectionofchemicals, thatcriteriaandmethodsofpostmortem
examinationand identificationoftumors haschanged over this
periodoftime, orthatthecriteriafordeterminingcarcinogenici-
ty have changed. However, these "false positives" do not
diminishthepositivevalueofmutagenicity foridentifyingpoten-
tial carcinogens. Theassociation appears so highthat it can be
argued thatchemicals withbiological and structural evidenceof
mutagenicpotential shouldbetestedonly todetermineifthey are
not carcinogenic, or in order to classify the relative biological
potentialofthemutagens. Mutagensdemonstratingtrans-species
potential represent a clearpotential hazard for human health.
Although the data derived from the Salmonella assay are
highly informativeaboutmutagenicpotential, theredoes notap-
peartobeanyrelationshipbetween rodentcarcinogenicity and
thedosesatwhichthechemical inducesmutations, thenumber
ortypesofSalmonella strains in which mutations are induced,
or the shapes ofthe dose-response curves. That is, a positive
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response in any ofthe Salmonella strains is informative about
mutagenic and carcinogenic potential, but none of the other
parameters improve ourunderstanding ofthe relativepotency of
thechemical, eitherforitsmutagenicity inother systemsorfor
the ability of the chemical to induce carcinogenic effects in
rodents.
Within the NTP, the identification ofpotential mutagens is
basedonanexaminationoftheprimary structureofthechemical
and testing using in vitroandin vivoshort-term tests. Apositive
response in any ofthe tests is based on both statistical and em-
pirical considerations andrequirestheindependentverification
of the original results, i.e., a repeatable positive or negative
response inacompletely independentassay. All ofthetests are
conducted undercode withoutknowledgeofthestructureofthe
chemical and many of its physical properties. This imposes
limitations on the identification of some types of potential
mutagens whereproblemsareencountered involvingsolubility,
reactivity with plastic, high toxicity, etc., factors that are often
difficulttoaccommodateinstandardizedprotocols. Therefore,
ithas been necessary toevolveprotocol modifications toensure
that substances such as thosethatarehighly volatileormay re-
quire different types ofmetabolism can be adequately tested.
Under somecircumstances the chemical may be studied for its
ability to induceeither micronuclei inperipheralbloodcells in
miceorforitsabilitytoinducemicronucleiorchromosomalaber-
rationsinbonemarrowcellsofratsormice. Chemicalsthatsubse-
quently demonstrate apositiveresponse inboththeSalmonella
andthein vivocytogeneticsassaysareconsideredtobeconfirmed
in vivomutagensandwillbepredictedtohaveahighprobability
ofinducingacarcinogeniceffectinthe2-yearbioassay. Converse-
ly, ifachemicalismutagenicinSalmonella, anegativeresponse
inan in vivo genetictoxicity testdoesnotdiminishtheimplica-
tion ofthe positive Salmonella response for carcinogenesis.
Nonmutagenic Carcinogens
In 1973, Ames and his co-workers (2) declaredthatcarcino-
gens are mutagens. However, the analysis ofthe mutagenicity
results from 114chemicalsstudiedforcarcinogeniitybytheNTP,
has shown that approximately 50% ofchemicals that are car-
cinogenic in rodentbioassays are notmutagens (28,34)andalso
lackevidenceofstructural featuresconsistentwithelectrophilic
potential (29,30). Incomparison, only48% ofthecarcinogens
in the same 114-chemical dataset werecarcinogenic inboth ro-
dentspecies, and theoverall concordancebetweenmiceand rats
for carcinogenicity and noncarcinogenicity was 69% (35).
The nonmutagenic carcinogens have been a focal point of
discussion and controversy because they have led to presump-
tionsabouttheinadequacy ofgenetictoxicity assaysforpredic-
ting rodent carcinogens. As stated previously, mutagenicity
assays identify chemicalsthathavethecapacity tointeractwith
DNA or other macromolecules either directly or following
metabolism. There are chemicals that lack such capacity for
direct interactionthatnonetheless maybegenotoxicbyvirtueof
their ability to indirectly affect DNA replication or repair or
chromosomemetabolismortoaffectotherpathwaysthatcangive
rise to heritablemutations. There hasbeen speculation thatthe
indirect induction ofmutations could be an important mecha-
nism. Forexample, somechemicals, by virtueofeffectsoncell
homeostasis or metabolism, by inducing inflammation,
or by inhibiting repairprocesses, could increase the amount of
damage toDNAresulting from an increase inoxidative radical
production (36-38). Various oxygenradicals areproduced asa
by-product ofnormal cellular metabolism, and avariety ofpro-
cesses normally exist to sequester such products and prevent
them fromcausing injuryinthecell. Inaddition, therearerepair
mechanisms to guard against inadvertent DNA damage. It is
possible that some chemicals couldalterany oneofthese com-
plex pathways, and the failure ofsuch protection systems could
give rise indirectly to an increase in mutations.
The patterns of carcinogenicity induced by nongenotoxic
chemicals arealsoofinterest. Asdescribed previously, apropor-
tionofmutagenicchemicalsproducedtumorsatspecific sitesand
often inducedtumorsacrossspeciesandatmultiplesites. Incon-
trast, a high proportion of the single-species, single-site car-
cinogens arenotmutagenic anddonotcontainstructural alerts.
Theresultsimplythatboththeprocessesandconsequencesofcar-
cinogenicity associated withexposuretononmutagens arefun-
damentallydifferentfromthoseresultingfromexposuretomany
mutagenic chemicals. Ames and Gold (36) have proposed that
nonmutageniccarcinogenesis in2-yearrodentbioassays islike-
lytobeaconsequenceonlyofthetoxiceffectsofchemicalsortheir
capacity foreffectson indirect induction ofmutations. Wehave
recently analyzedtherelationshipsbetweenthesubchronicand
chronicnonneoplasticeffectsof31 chemicalsthathavebeentested
forcarcinogenicity in2-yearrodentbioassays (39). Theresultsof
this study didnot reveal any consistent association between the
capacityofchemicalstoinducechronic (nonneoplastic)toxicity
and subsequent tumor induction. Rather, there were examples
wherebothmutagenicandnonmutagenicchemicalsinducedtoxic
effects, manyofwhichshowedproliferativecharacteristics such
ashyperplasia,thatdidnotresultintumorinduction. Mutagenic
chemicals, by and large, tend to be more toxic than do non-
mutagens (35), but there were sites oftumorigenesis by both
mutagensandnonmutagensthatwereassociatedwithtoxicityand
othersthatwerenot. Theseresultsfailedtosupportadirectrela-
tionship between sustained tissue-specific toxicity andtumori-
genic potential. The results imply that properties ofchemicals
otherthantheirabilitytoinduceeithermutationsorspecifictissue
toxicity maybeimportant inthe induction orpromotion ofcar-
cinogenic processes.
Thedifficultyintryingtoidentifythenongenotoxic chemicals
that have carcinogenic potential represents a major problem.
Among such chemicals represented in the NTP database are a
diversityofstructuralandphysicalgroupings, andithasnotbeen
possible thus far to identify any particular features that have
predictive value. A significant number of nonmutagenic sub-
stanceswereincludedamongthe44chemicalsthatwereusedto
predictpotential carcinogenicity, asdescribedbelow. Forthese
chemicals, theonlyanimalinformationavailablethatmightrelate
totheircarcinogenicpotentialwasthepatternsofsubchronictox-
icity thatthey induced inthe two rodent species. In an effort to
challengetherelationshipsbetweensuchtoxicityandtumorigeni-
city,theavailableevidencewasusedineffortstopredictwhether
such chemicals would becarcinogenic. When these results are
evaluatedtheywillprovideanadditionaltestoftheassociationbe-
tweentoxicityandcarcinogenicity. Thus,theproblemofpredic-
tingcarcinogenicpotentialremains. Thestrategythatiscurrently
beingusedbytheExperimentalCarcinogenesisandMutagenesis
Branch (ECMB) ofNIEHS is to seekabetterunderstandingof
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the mechanismsbywhichsuchchemicalsmayact,ratherthanto
randomlyseekmethodsthatmayhavesomepredictivecapacity.
Ifsomecommon mechanisms orbiological effectscanbeiden-
tifiedformanynonmutageniccarcinogens,theywouldleadtoara-
tional and logicalbasisfordevelopingshort-termtestsystemsthat
wouldprovideuseful informationforpredictingcarcinogenicity.
Mechanisms of Carcinogenicity of
Nonmutagenic Carcinogens
There havebeen a varietyofmechanismsproposedtoaccount
forthe carcinogenicity ofnonmutagenic chemicals. Prominent
among theseideas is theinductionofoxidativedamage. Apar-
ticularexampleofthis mechanism istheabilityofchemicals to
inducethe proliferationofperoxisomes, whichmaybeasignifi-
cant source ofmutagenic oxygen radicals. Thus, the proposed
mechanisms for many chemicals classified as "nonmutagens"
may involve some form ofindirect mutagenesis. The evidence
that links theinductionofsomatic mutationswiththegenesisof
cancer iscompelling. Several linesofevidencestrongly support
the association. They include the identification of specific
chromosomedamage in many rodentand human tumors (40),
the identification of oncogenes that have been activated by
specific mutations (41), ortheinactivationoftumor-suppressor
genesalsobymutation(42), and, ofcourse, themutagenicityof
known human carcinogens (43). The scientific momentum
createdby these linesofevidencesupportthemultistageconcept
ofcarcinogenesis. Thereisalsothe recentfindingofaseriesof
gene and chromosomal mutations inhumancolorectal cancers
(44). In addition, the somatic mutationhypothesisisconsistent
withexperimentaltwo-stagemodelsofinitiationandpromotion.
Although theselinesofevidence arecompelling, therearealso
other lines ofevidence that support alternative mechanisms of
carcinogenesis. As aresultoftheNTP, andotherstudies, wenow
know thatthere are moredifferencesamongthemutagenic and
nonmutagenic carcinogens than simply their mutagenicity in
Salmonella (28,45), supporting the existence of alternative
mechanisms ofcarcinogenesis. These alternativemechanisms
include the induction ofcell proliferation, induction ofperox-
isomes, changes inmethylation patterns, changes ingeneexpres-
sion, activation of oncogenes, etc. This is also an area of in-
vestigation wherechemical structure-activity relationships may
be useful. Among the evidence supporting these alternative
mechanisms isthefrequentlyobservedregressionorremodeling
of neoplasms and the existence of noninduced spontaneous
tumors in rodents that have a genetic component in their
expression.
The major problem with the concept ofnonmutagenic car-
cinogenesis ishowtoaccountfortheheritablephenotypicchange
that mustaccompany theevolutionofneoplasmsandhow to ex-
plain thegeneticchangesthatareassociatedwithmany tumors.
Ithasbeenproposed thatmanyoftheprocessesthatgiveriseto
cancer cells representanalogs ofthechanges thatoccurduring
normal growth anddifferentiation. Forexample, heritablepat-
ternsofgeneexpression areresponsiblefortheemergenceofdif-
ferentiated cells from stemcellpopulations, forpatterns ofter-
minal differentiationandapoptosis, andforthemaintenance of
differentiated characteristics oforgans and tissues.
Relatively little is knownabouthowpatternsofgeneexpress-
ionareheritably altered. Themethylationofcytosinebaseshas
been implicated in some types of transcriptional regulatory
mechanisms, butthisclearlydoesnotrepresenttheonlymeans
by which gene expression is controlled. The association of
histone proteins can also affect the capacity of genes to be
transcribed, butbeyondthesemechanisms thecomplexassocia-
tionsamongtranscriptionalfactors, polymerases, andtranscrib-
ablegenes isyettobedefined. Webelievethatthetranscriptional
apparatus is aplausibletargetforheritablechanges inducedby
chemicals. Theadaptivecapacityofmammaliancells inculture
is well demonstrated. Cells removed from the highly regulated
and controlledenvironment ofthe body are plated onto plastic
surfaces inthepresenceofforeign serum, and cellpopulations
withthecapacity forextendedgrowthemerge. This sameadap-
tivecapacitymightbeexpressed in vivo in thepresenceofsus-
tained toxicity. For example, in the 2-year rodent bioassays,
although efforts are made to limit the level of toxicity to a
maximum-tolerated dose, the consequences of long-term ex-
posure often cannot be anticipated from subchronic toxicity
studies. Theanimals arethusinadvertentlyexposed to levelsof
chemicalsthatbring aboutvarious types oforgan-specific tox-
icity. In order for cells to survive in the presenceoftoxicity, a
variety ofchanges in gene expression occur, and in order for
daughter cells to survive in the presence ofsustained toxicity,
they too mustexpressthe samealteredpatternofgeneexpress-
ion. Itisplausiblethatsustained, alteredgeneregulation, where
proliferationisalsodrivenbytoxiceffects, cancreate situations
in which further alterations in genomic regulation occur and
couldbeasubstrate fromwhichchromosomeandothergenetic
alterations emerge. Farber and Rubin (46) have described a
similarselectiveprocessthattheycallstepwiseadaptation, which
appears to be a plausible mechanism of epigenetic or non-
genotoxiccarcinogenesis. Thechallengeforthefutureistobetter
identify the phenomenon ofnongenotoxic carcinogenesis and
define experimental systems in which these hypotheses can be
tested.
Prediction of Carcinogenicity
The rodentcarcinogenesisbioassay presents auniqueoppor-
tunity forassay validationbecausechemicalsthataresubjected
tothetestingarenotdefinitively knowntobeeithercarcinogenic
ornoncarcinogenic. Thus, the informationgenerated from an in
vitro assay system, and other information about the chemicals'
structureandchemical andbiologicalproperties, canbeused to
predictthepotential resultsofarodentbioassay inaprospective
approachtovalidation. Wearecurrentlytestingtherelationships
among chemical structure, Salmonella mutagenicity, and car-
cinogenicity that are advocated in this paper. In this effort, 44
chemicalsthatwerein somephaseoftherodentbioassay, butfor
whichtheresultsoftheassay werenotyetknown, wereselected
only onthebasisthatthey wereunderassay within aparticular
timeframe, i.e, 1990-1992. Dataonthe structureandshort-term
biological properties ofthechemicals werecompiled and used
for predicting their carcinogenic potential. These predictions
were published in Mutagenesis (47), and the editor ofMuta-
genesis invited other groups with different predictive
methodologies toalso-submitforpublicationtheirpredictions on
these same chemicals. Six additional manuscripts were pub-
lished, predicting at least aportion ofthe 44 chemicals. When
themajorityofthebioassays arecompleted in 1993, therewill be
anunprecedentedopportunity tochallengethehypothesisofthe
relationshipbetweenmutagenicity andcarcinogenicity, aswell
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as of the ability of various predictive strategies, including
computer-assisted methods.
Future assays both for subchronic toxicity and for carcino-
genicity will provide the opportunity to challenge new
hypotheses, as well as new methods ofpredictingcarcinogenici-
ty. The evaluation of all of these methods are, of course,
predicated ontheassumption thattherodentbioassay isan une-
quivocal, or at least the best available, method for carcinogen
identification against which all other methods should be
measured. This issue has been subject to extensive debate, but
most arguments defer to the fact that, despite theuncertainties
and limitations of2-yearrodentstudies, there areasyet noother
reliablemethodsby whichcarcinogenicpotential canroutinely
be assessed. Thus, for the foreseeable future, all alternative
methodsofidentifyingcarcinogens willbemeasuredagainstthe
results of2-year rodent carcinogenicity tests.
Weadvocatethe useofpredictivetoxicology forthedevelop-
ment of other methodologies. However, ifthe carcinogenesis
bioassays are used as experimental tools fortesting alternative
methods, theprocessofvalidation canbebetterdefined, andthe
period ofevaluation can betightlycircumscribed. Forexample,
the ECMB is attempting to assess the relationship between
chemical substructure andorgan-specific toxicity. Theextensive
database established by the NTP on the subchronic toxicity of
chemicals is even larger than that available for long-term car-
cinogenicity results and provides an unparalleled source ofin-
formation onorgan-specific toxicity. Theassayshavebeen con-
ducted in a systematic manner that allows comparisons within
and among assays and chemicals. Various computer-assisted
methodologies are currently being evaluated to determine if
specific chemical substructures can be identified that are
associated withorgan-specifictoxicity. Theidentificationofsuch
structural alerts canthenbeexperimentallychallengedbyusing
this information topredictthe outcomeoffuturesubchronic tox-
icity assays. This concept can be used to assess any alternative
methodologies purported to be able to substitute forlong-term
animal studies. But it is only the extensive and well-developed
database thathas been created from animal studies that makes
this approach possible.
Transgenic Cell and Mouse Models
Thedevelopment ofmethods to introduceforeign genes into
cultured cells or to inject foreign genes into the pronuclei of
zygotes is an importantadvance ingeneticmethodologies. Ap-
plication of such methods has resulted in the development of
transgenic cultured cells and mouse lines that carry stable in-
tegratedcopiesofforeigngenesthat canbetargetedforexpres-
sion incertaintissues orunderspecificenvironmentalconditions
and whichprovideuniquetargets tostudychemical-biological
interactions. Model systemsthat arebeinggeneratedwiththese
technologies will provideimportant tools in bothcarcinogenesis
and genetic toxicology. Among the most important models
developed thus far thathaveapplications inboth fields are mouse
lines thatcarry insertedbacterial genesthat canberecovered, in
which mutations canbedetectedandquantitated and forwhich
mutational spectra canbedetermined. The two mostprominent
transgenic mouse linescurrentlybeinginvestigatedinvolvethe
introductionofbacterial lacl orlacZ genes, whicharecarried as
stablemultigenetandems. Thetargetgenes can besubsequent-
ly recoveredusing packaging extracts ofbacteriophage, plated
onto sensitive E. coli strains, and the induced mutations quan-
titated. Thesemiceoffertheopportunity forthe firstqualitative
as well as quantitative measurements of chemical-induced,
tissue-specific, somaticmutationsinmice, andwillallowadeter-
mination of whether correlations exist between sites of car-
cinogenesis andmutagenesis inducedby carcinogens. They will
alsoprovide importantmodels with whichto studytheproblem
of indirect or oxidative mutagenesis. Preliminary studies are
underway, butwithin thenext few years significant amounts of
information will accrue about the tissue-specific mutagenic
potentialofavarietyofchemicals. Theability torecovermutated
DNAandtodeterminemutational spectraprovidesamethodby
which the action ofspecific chemicals can be fingerprinted.
A secondapplicationoftransgenicmethodologyistheevalua-
tionofmicecarryingoncogenesorproto-oncogenesthatactas
additionaltargetsforpotentialcarcinogens. Thesesystems will
providetheopportunitytoassessnewmethodsthatmaypermit
a reduction in the use of rodents in 2-year bioassays for car-
cinogen identification. They will alsoprovidetheopportunity to
study chemical-gene interactions and the role ofchemicals at
various stages in theprocesses ofneoplasia in ways in which it
has notbeenpossible to conceive ofbefore the development of
suchmodels. TheECMBhasinitiatedpreliminarystudiesofthe
effectsofchemicals inthreetransgenicmouselinesthatcarryon-
cogenes under the control of mouse mammary tumor virus
(MMTV) regulatory sequences. Thethreeoncogenesv-Ha-ras,
c-myc, and c-neu are thus all regulated by glucocorticoid-
sensitive MMTV-LT-Relements. Thepredominantexpression
ofthetransgenes isdirectedtomammary tissueand, toa lesser
extent, other sensitive tissues. Thesethree transgenic lines are
being studied fortheir responses to selected chemicals. This is
designedtodeterminewhethercarcinogens can specifically ac-
celerate oralterthepatternoftumorinduction andthusprovide
useful modelsforshort-termdetectionofcarcinogensundercon-
ditionsinwhichchemicalscanbemetabolized, detoxified, and
distributed within the body by normal pathways.
A third line of research involves the use of cultured mam-
maliancells intowhichforeigngenescanbe introducedby either
transfection or transduction. The latter method uses selected
retroviral vectors, whichprovide a more efficientmeans ofin-
troducingforeigngeneswith morecomplicatedconstructs. This
methodology is being used to determine the effects ofselected
proto- or activated oncogenes on the growth properties and
chemical responsivenessofculturedcells. Aparticularproblem
towhichthesestudies isdirectedistounderstandbetterthedif-
ferential responses to chemical carcinogens among rodent and
human cells. Rodent cells generally adapt to growth in cell
culture, readily acquire extended life spans, and respond to a
varietyofchemicalcarcinogensthatinducemorphological and
malignanttransformation. Human cells, on the other hand, do
notreadily undergochanges toextended life spanupongrowth
incultureandtendtomaintainafinitelifespanandahighdegree
of genome stability. Unless they contain specific oncogenes,
human cells are also generally unresponsive to the effects of
chemicalcarcinogens. Animportantissuetobeaddressedisthe
biologicalbasisoftherelativeresistanceofhumancells. Theap-
proachcurrentlybeing studied is tointroduce selectedgenes into
normalhumanfibroblastsandtodeterminetheeffectsongrowth
characteristics and chemical sensitivity.
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Conclusions
Theeffortsofthepasttwodecadesservetoreaffirmthecom-
plexity ofthecarcinogenic process. Theanticipated simplerela-
tionship between mutagenicity and carcinogenicity was not
borne out by results from the genetic toxicity and rodent car-
cinogenicity assays. Thecomplexity ofchemicals, togetherwith
thecomplexity oftheorganisms, thenumbersofgeneproducts
and genes with which thevarious moieties ofthe chemical can
interact, andtherolesofduration, route, andexposuredose, all
contributetotheoverallcomplexity. Invitromethodologies and
bioassays arebiological tools for helping us to understand the
natureofchemicalproperties. Theresultshaveclearlydelineated
twogeneralclasses ofcarcinogens: those thataremutagenic in
vitroandcontainchemicalmoietiescapableofreactingaselec-
trophiles, andthose thatare not. Themutagenicchemicals sup-
port a mechanism ofcarcinogen induction that is amenable to
studyby specificcellular, biochemical, andgenetic techniques.
Thenonmutageniccarcinogensencompassavarietyofchemical
structuresandbiological responses. Thereisnoreasontobelieve
that this group of carcinogens is effective through a unified
mechanism. Some chemicals are believed to be activethrough
the intracellular generation of oxygen radicals, others are
believed to act by first inducing cell proliferation, and others
through thedisruption ofnormalcellregulatoryeffectsorcell-
cycle kinetics.
Thenonmutageniccarcinogens, therefore, presentachallenge
to identify and characterize the cellular mechanisms that are
capableofinitiating orpromotingthecarcinogenicresponse. The
subsequent relationshipsamong results obtainedfromthese in
vitro and rodent systems and the induction or expression of
cancers in humans remains another step to be addressed. The
results described inthis paperoutlineinformationupon which
future efforts to seek answers to thesequestions can be based.
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